Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long Covid fatigue among people receiving care from specialist long Covid clinics, according to new findings from a large clinical trial led by UCL (University College London) and UCLH.

Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr Laurence Dobbie of the Department of Population Health Sciences, King’s College London, with an international team of 26 authors.

Two journals specialising in reporting on the links between biology and mental health have reported significant increases in the number of times articles have been cited by scientists. The editors cite technical improvements, but also growing interest in the biological basis of mental health processes as the likely reasons.

Chronic kidney disease (CKD) is common, largely silent, and serious. Most people who have the condition do not realize they have it, while it sharply raises the risk of heart attacks, strokes, kidney failure and early death. Over the past decade, the share of American adults living with CKD has remained consistent. Roughly one in seven U.S. adults — about 15% — had CKD in 2013, and approximately 1 in 7 still had it in 2023. What has changed is the type of kidney disease.

In a new study, researchers have found that the proportion of Americans with kidney disease driven by diabetes rose from 4.7% to 5.7% (about a 30% relative increase), while kidney disease not linked to diabetes held steady.